[Federal Register Volume 65, Number 229 (Tuesday, November 28, 2000)]
[Notices]
[Pages 70920-70921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30155]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 00N-1620]
2001 National Antimicrobial Resistance Monitoring System (NARMS)
Scientific Meeting; Public Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
following meeting entitled ``2001 NARMS Scientific Meeting.'' The topic
to be discussed is the results from NARMS and related antimicrobial
resistance research.
DATES: The public meeting and poster session will be held on March 15
and 16, 2001, from 8:30 a.m. to 5 p.m. An early evening poster session
and social hour will be held on March 15, 2001, from 5:30 p.m. to 7:30
p.m. Submit written comments by January 29, 2001.
ADDRESSES: The public meeting will be held at the DoubleTree Hotel,
1750 Rockville Pike, Rockville, MD. Submit written comments to the
Dockets Management Branch (HFA-305), Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kathy S. Hemming, Center for
Veterinary Medicine (HFV-250), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-827-0184, 301-827-7625.
For information about the poster session contact: Charlotte A.
Spires, Center for Veterinary Medicine (HFV-250), Food and Drug
Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6853,
e-mail: [email protected].
Registration: Registration is required. There is no registration
fee for the meeting. Limited space is available, and early registration
is encouraged. Logistics for the meeting and the registration form are
available on the Internet at http://www.fda.gov/cvm/fda/mappgs/registration.html. Please send the registration form to Kathy Hemming
(address above). Additional information about the meeting and the
agenda will be available on the Internet (Internet site above) before
the meeting. If you need special accommodations due to a disability,
please contact the DoubleTree Hotel at least 7 days in advance, 800-
222-8733.
Poster abstracts: Abstract preparation and submission information
are available on the Internet at http://www.fda.gov/cvm/fda/mappgs/registration.html. Instructions and submission forms may be downloaded
in MSWord or WordPerfect. Please send submission of poster abstract to
Charlotte Spires (address above) by January 15, 2001.
SUPPLEMENTARY INFORMATION:
I. Background
The National Antimicrobial Resistance Monitoring System (NARMS) was
established in 1996 as a collaborative effort among FDA, U.S.
Department of Agriculture (USDA), and the Centers for Disease Control
and Prevention (CDC). The NARMS was established in response to
recommendations of several groups, including a 1995 task force of the
American Society of Microbiology, to establish a national system in the
United States to monitor levels of antimicrobial resistance in both
animals and humans. The NARMS program prospectively monitors changes in
susceptibilities of human and animal enteric bacteria to 17
antimicrobial drugs. Bacterial isolates are collected from human and
animal clinical specimens, from healthy farm animals, and raw product
from food animals. The objectives of the system include: (1) To provide
descriptive data on the extent and temporal trends of antimicrobial
susceptibility in Salmonella and other enteric organisms from human and
animal populations, (2) to facilitate the identification of resistance
in humans and animals as it arises, and (3) to provide timely
information to veterinarians and physicians. The ultimate goal of these
activities is to prolong the lifespan of approved drugs by promoting
prudent and judicious use
[[Page 70921]]
of antimicrobical drugs and to identify areas for more detailed
investigation.
The NARMS program is designed as two nearly identical parts: an
animal arm and a human arm. Animal-origin enteric isolate
susceptibility testing is conducted at the USDA, Agricultural Research
Service's (ARS) Russell Research Center in Athens, Georgia. Sources of
nationwide animal-origin isolates are: (1) Raw product collected from
federally inspected slaughter and processing plants, (2) clinical
specimens from the National Veterinary Sevices Laboratory and
Veterinary Diagnostic Laboratory Sentinel Sites, (3) healthy farm-
animal isolates from USDA National Animal Health Monitoring System
(NAHMS) studies, and (4) on-farm studies conducted by ARS. Human-origin
isolates are submitted by 17 State and local Departments of Health for
testing that is conducted at the National Center for Infectious
Disease, CDC, in Atlanta, Georgia. The participating human sites
currently include: California (CA); Colorado; Connecticut; Florida;
Georgia; Kansas; Los Angeles, CA; Maryland; Minnesota; Massachusetts;
New Jersey; New York City; New York State; Oregon; Tennessee;
Washington; and West Virginia. Animal and human isolates currently
monitored in NARMS are non-typhoid Salmonella, Campylobacter,
Escherichia coli, and Enterococci. Human isolates also include
Salmonella typhi and Shigella. Listeria andVibrio will be added to the
list of human isolates in 2001.
The CDC/NCID and USDA/ARS provide the NARMS results annually in
comprehensive summary reports. These reports are available on the CDC
and FDA/CVM web sites. Additionally periodic public meetings are held
to present NARMS results and provide a forum for presentation of other
related antimicrobial resistance research.
II. Submission of Comments
Interested persons may submit to the Dockets Management Branch
(address above) written comments regarding this meeting by January 29,
2001. Two copies of any comments are to be submitted, except that
individuals may submit one copy, or by fax to 301-827-6870. Comments
are to be identified with the docket number found in the brackets in
the heading of this document. Received comments may be seen in the
Dockets Management Branch between 9 a.m. and 4 p.m., Monday through
Friday.
Dated: November 17, 2000.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 00-30155 Filed 11-27-00; 8:45 am]
BILLING CODE 4160-01-F